Comparative hemocompatibility assessment of fibrin/heparin-coated and PMEA-coated flow diverters
Journal of Materials Science: Materials in Medicine · 2026
DOI: 10.1007/s10856-026-07087-2 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Materials Science: Materials in Medicine, 2026. Verfasst von Huan Wei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic and Cardiovascular Surgery, University Hospital Tuebingen, Tuebingen, Germany. Hauptthemen laut MEDLINE: Heparin, Coated Materials, Biocompatible, Fibrin, Polymers. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Flow diverters play an important role in the endovascular treatment of intracranial aneurysms; however, their use can be associated with thromboembolic complications. Thus, in recent years, flow diverters with surface coatings have been developed to prevent thrombus-related complications. In this study, the hemocompatibility of the flow diverters FRED X with poly(2-methoxyethyl acrylate) (PMEA) coating and the DERIVO 2heal with fibrin/heparin coating, as well as the uncoated DERIVO 2 flow diverter, was evaluated using an in vitro blood circulation model. Using enzyme-linked immunosorbent assay (ELISA), biomarkers of thrombocytes (β-thromboglobulin (β-TG)), coagulation (thrombin-antithrombin complex (TAT)), complement system (SC5b-9), and inflammation (PMN elastase) activation were analyzed. Further analyses comprised thrombogenicity assessment by scanning electron microscopy and measurement of blood cell counts and hemolysis. The uncoated DERIVO 2 flow diverter exhibited increased coagulation and platelet activation, accompanied by enhanced adhesion of platelets to the blood-contacting surfaces. In contrast, both the FRED X and the DERIVO 2-heal flow diverter could effectively reduce the coagulation (TAT) and platelet activation (β-TG) and prevent the adhesion of platelets. Notably, DERIVO 2heal flow diverter induced significantly lower activation of the complement system (SC5b-9) and reduced inflammatory response (PMN elastase) compared to FRED X flow diverter. These findings indicate the improved hemocompatibility of the fibrin/heparin-coated DERIVO 2heal flow diverter and its potential to reduce thromboinflammatory complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Thoracic and Cardiovascular Surgery, University Hospital Tuebingen, Tuebingen, Germany.
- Department of Chemistry and Physics of Surfaces and Biointerfaces, Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague 6, Czechia.
- Department of Thoracic and Cardiovascular Surgery, University Hospital Tuebingen, Tuebingen, Germany. meltem.avci-adali@uni-tuebingen.de.
Zitieren
APA
Wei, H., Riedel, T., Riedelová, Z., Wolf, M., Schlensak, C., & Avci-Adali, M. (2026). Comparative hemocompatibility assessment of fibrin/heparin-coated and PMEA-coated flow diverters. Journal of Materials Science: Materials in Medicine. https://doi.org/10.1007/s10856-026-07087-2
Vancouver
Wei H, Riedel T, Riedelová Z, Wolf M, Schlensak C, Avci-Adali M. Comparative hemocompatibility assessment of fibrin/heparin-coated and PMEA-coated flow diverters. Journal of Materials Science: Materials in Medicine. 2026. doi:10.1007/s10856-026-07087-2
BibTeX
@article{Wei2026,
author = {Wei, Huan and Riedel, Tomáš and Riedelová, Zuzana and Wolf, Melanie and Schlensak, Christian and Avci-Adali, Meltem},
title = {Comparative hemocompatibility assessment of fibrin/heparin-coated and PMEA-coated flow diverters},
journal = {Journal of Materials Science: Materials in Medicine},
year = {2026},
doi = {10.1007/s10856-026-07087-2}
}
EUVIMED